SARS-CoV-2 vaccine development and challenges
In 2020, the SARS-CoV-2 epidemic has made the world’s public system withstand extremetests. Therefore, it is urgently expected to develop a vaccine that can effectively prevent the SARS-CoV-2in the worldwide. At present, more than 200 vaccines are in the preclinical research or undergoing clinicaltr...
I tiakina i:
| Ngā kaituhi matua: | , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Chinês |
| I whakaputaina: |
Lanzhou University Press
2021-03-01
|
| Rangatū: | 生物医学转化 |
| Ngā marau: | |
| Urunga tuihono: | http://swyxzh.ijournals.cn/swyxzh/article/html/20210101?st=article_issue |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|